首页> 外文期刊>Journal of Lipid Research >A NEW MUTATION IN THE GENE FOR LYSOSOMAL ACID LIPASE LEADS TO WOLMAN DISEASE IN AN AFRICAN KINDRED
【24h】

A NEW MUTATION IN THE GENE FOR LYSOSOMAL ACID LIPASE LEADS TO WOLMAN DISEASE IN AN AFRICAN KINDRED

机译:非洲人种中溶酶体脂肪酶导致沃尔曼病的基因突变

获取原文
获取原文并翻译 | 示例
           

摘要

Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity and genetic defects of lysosomal acid lipase (LAL). The strikingly more severe course of WD is caused by genetic defects of LAL that leave no residual enzymatic activity. Mutations at the exon 8/intron 8 transition of the LAL gene have been identified in several CESD and WD patients and are responsible for the manifestation of the disease. We have determined the genetic defect in a 3-month-old boy of African origin affected by WD. No enzymatic activity of the lysosomal acid lipase was detectable in white blood cells and cultured fibroblasts. Analysis of his LAL cDNA and genomic DNA revealed that he was homozygous for a mutation at position -3 of the exon 8 splice donor site. A C --> T transition leads to a nonsense codon and to a premature termination of the LAL protein at amino acid 277. Due to this mutation, a shorter LAL mRNA species was also generated that lacked exon 8 and was deficient of the nonsense codon. As a consequence, the protein synthesis proceeded to the natural termination codon, but the enzyme generated had an internal deletion of 24 amino acids (254-277) and was also inactive. These findings, together with our previous observations when analyzing the mutations in WD and CESD patients lead to the conclusion that the more severe WD is due to mutations that absolutely abolish lysosomal acid lipase (LAL) enzyme activity and the cholesteryl ester storage disease phenotype is due to mutations that allow some residual LAL activity to be manifested. [References: 13]
机译:胆固醇酯贮积病(CESD)和沃尔曼病(WD)都是与活性降低和溶酶体酸性脂肪酶(LAL)的遗传缺陷相关的常染色体隐性遗传疾病。 WD的更为严重的病程是由LAL的遗传缺陷引起的,该遗传缺陷没有残留的酶活性。 LAL基因的外显子8 /内含子8转变处的突变已在几位CESD和WD患者中得到鉴定,并负责该疾病的表现。我们已经确定了一个患有WD的非洲裔3个月大男孩的遗传缺陷。在白细胞和培养的成纤维细胞中未检测到溶酶体酸性脂肪酶的酶活性。对他的LAL cDNA和基因组DNA的分析显示,他在外显子8剪接供体位点-3位置的突变是纯合的。 C→T转换会导致无义密码子,并导致LAL蛋白在277位氨基酸上提前终止。由于这种突变,还产生了一个较短的LAL mRNA,它缺少外显子8,并且缺乏无义密码子。结果,蛋白质合成进行到天然终止密码子,但是所产生的酶具有24个氨基酸(254-277)的内部缺失并且也是无活性的。这些发现以及我们以前在分析WD和CESD患者突变时的观察结果得出的结论是,更严重的WD是由于绝对消除溶酶体酸性脂肪酶(LAL)酶活性和胆固醇酯贮积病表型的突变引起的突变,使一些残留的LAL活性得以表现。 [参考:13]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号